This is the authors' abstract. We don't add key points for this paper.
RATIONALE: Transient abnormal myelopoiesis with mutations in GATA1 gene can be self-alleviated after 3 to 4 months of birth in term infant, however, the premature infant with this disease in our research achieved remission earlier. PATIENT CONCERNS: A 10-hours-old girl was diagnosed with transient abnormal myelopoiesis with GATA1 mutation. DIAGNOSIS: Transient abnormal myelopoiesis in a premature infant was suspected. INTERVENTIONS: The patient received anti-infection, liver protection, hydration, and alkalization treatments for leukocytosis. OUTCOMES: After admission, the infant was diagnosed with TAM with GATA1 mutation after completing bone marrow cytology, whole-exon gene detection, and FISH detection. The GATA1 gene mutation of this baby turns negative a month later. LESSONS: Transient abnormal myelopoiesis differs from congenital leukemia. Most children can self-alleviate after 3 to 4 months of birth, and GATA1 mutation turns negative. Since some children with transient abnormal myelopoiesis may develop myeloid leukemia of Down syndrome, continuous follow-up is required once transient abnormal myelopoiesis is diagnosed for early detection and treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: